144 related articles for article (PubMed ID: 37106416)
1. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
Marañón P; Isaza SC; Fernández-García CE; Rey E; Gallego-Durán R; Montero-Vallejo R; de Cía JR; Ampuero J; Valverde ÁM; Romero-Gómez M; García-Monzón C; González-Rodríguez Á
Biomark Res; 2023 Apr; 11(1):46. PubMed ID: 37106416
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
Marañón P; Fernández-García CE; Isaza SC; Rey E; Gallego-Durán R; Montero-Vallejo R; de Cía JR; Ampuero J; Romero-Gómez M; García-Monzón C; González-Rodríguez Á
Biomark Res; 2022 May; 10(1):35. PubMed ID: 35614516
[TBL] [Abstract][Full Text] [Related]
3. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Loomba R; Jain A; Diehl AM; Guy CD; Portenier D; Sudan R; Singh S; Faulkner C; Richards L; Hester KD; Okada L; Li XJ; Mimms L; Abdelmalek MF
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1867-1876.e3. PubMed ID: 30448594
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
Shelley K; Articolo A; Luthra R; Charlton M
BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593
[TBL] [Abstract][Full Text] [Related]
5. Niacin regresses collagen content in human hepatic stellate cells from liver transplant donors with fibrotic non-alcoholic steatohepatitis (NASH).
Ganji S; Hoa N; Kamanna J; Kamanna VS; Kashyap ML
Am J Transl Res; 2022; 14(6):4006-4014. PubMed ID: 35836902
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
[TBL] [Abstract][Full Text] [Related]
7. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study.
Dvorak K; Stritesky J; Petrtyl J; Vitek L; Sroubkova R; Lenicek M; Smid V; Haluzik M; Bruha R
PLoS One; 2014; 9(10):e111551. PubMed ID: 25350286
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
Kluwe J; Pradere JP; Gwak GY; Mencin A; De Minicis S; Osterreicher CH; Colmenero J; Bataller R; Schwabe RF
Gastroenterology; 2010 Jan; 138(1):347-59. PubMed ID: 19782079
[TBL] [Abstract][Full Text] [Related]
9. The Potential Role of Fatigue in Identifying Patients With NASH and Advanced Fibrosis Who Experience Disease Progression.
Younossi ZM; Stepanova M; Myers RP; Younossi I; Henry L
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):970-977.e1. PubMed ID: 35533993
[TBL] [Abstract][Full Text] [Related]
10. Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis.
Angelini G; Panunzi S; Castagneto-Gissey L; Pellicanò F; De Gaetano A; Pompili M; Riccardi L; Garcovich M; Raffaelli M; Ciccoritti L; Verrastro O; Russo MF; Vecchio FM; Casella G; Casella-Mariolo J; Papa L; Marini PL; Rubino F; le Roux CW; Bornstein S; Mingrone G
Gut; 2023 Feb; 72(2):392-403. PubMed ID: 35820779
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
12. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
13. Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.
Larsen FT; Hansen D; Terkelsen MK; Bendixen SM; Avolio F; Wernberg CW; Lauridsen MM; Grønkjaer LL; Jacobsen BG; Klinggaard EG; Mandrup S; Di Caterino T; Siersbæk MS; Indira Chandran V; Graversen JH; Krag A; Grøntved L; Ravnskjaer K
JHEP Rep; 2023 Feb; 5(2):100615. PubMed ID: 36687468
[TBL] [Abstract][Full Text] [Related]
14. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
15. Serous BMP8A has Clinical Significance in the Ultrasonic Diagnosis of Thyroid Cancer and Promotes Thyroid Cancer Cell Progression.
Liu K; Gao M; Qin D; Wang H; Lu Q
Endocr Metab Immune Disord Drug Targets; 2020; 20(4):591-598. PubMed ID: 31656161
[TBL] [Abstract][Full Text] [Related]
16. Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis.
Cengiz M; Ozenirler S; Elbeg S
J Gastroenterol Hepatol; 2015 Jul; 30(7):1190-6. PubMed ID: 25684563
[TBL] [Abstract][Full Text] [Related]
17. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Younossi ZM; Anstee QM; Wai-Sun Wong V; Trauner M; Lawitz EJ; Harrison SA; Camargo M; Kersey K; Subramanian GM; Myers RP; Stepanova M
Gastroenterology; 2021 Apr; 160(5):1608-1619.e13. PubMed ID: 33307033
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive diagnosis of non-alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review.
Eguchi Y; Wong G; Akhtar O; Sumida Y
Hepatol Res; 2020 Jun; 50(6):645-655. PubMed ID: 32307859
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
